These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8100267)

  • 21. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
    Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
    Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes.
    Artini M; Nisini R; Missale G; Costanzo A; Accapezzato D; Balsano C; Barnaba V; Levrero M
    Viral Immunol; 1995; 8(2):63-73. PubMed ID: 8825291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
    J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.
    Barrett L; Gallant M; Howley C; Bowmer MI; Hirsch G; Peltekian K; Grant M
    BMC Immunol; 2008 Jun; 9():28. PubMed ID: 18554409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
    Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.
    Day CL; Lauer GM; Robbins GK; McGovern B; Wurcel AG; Gandhi RT; Chung RT; Walker BD
    J Virol; 2002 Dec; 76(24):12584-95. PubMed ID: 12438584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.
    Sansonno D; Iacobelli AR; Cornacchiulo V; Iodice G; Dammacco F
    Clin Exp Immunol; 1996 Mar; 103(3):414-21. PubMed ID: 8608640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones.
    Diepolder HM; Gruener NH; Gerlach JT; Jung MC; Wierenga EA; Pape GR
    J Virol; 2001 Sep; 75(17):7803-10. PubMed ID: 11483723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
    Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
    Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial NS4 mosaic antigen of hepatitis C virus.
    Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
    J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology.
    Blight K; Rowland R; Hall PD; Lesniewski RR; Trowbridge R; LaBrooy JT; Gowans EJ
    Am J Pathol; 1993 Dec; 143(6):1568-73. PubMed ID: 8256849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell clones derived by CD3 stimulation from hepatitis C virus explanted liver tissue are not representative of dominant clones present in vivo.
    Davey MP; Rosen HR; Woody CN; Haley DP; Kurkinen J; Lewinsohn DM
    Liver Transpl; 2001 Aug; 7(8):716-23. PubMed ID: 11510018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses in hepatitis C virus infection.
    Spengler U; Lechmann M; Irrgang B; Dumoulin FL; Sauerbruch T
    J Hepatol; 1996; 24(2 Suppl):20-5. PubMed ID: 8836885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C.
    Chiang BL; Yang PM; Hwang LH; Wang JM; Kao SF; Pan CH; Chi WK; Chen PJ; Chen DS
    J Biomed Sci; 1998; 5(4):290-6. PubMed ID: 9691222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.
    Löhr H; Treichel U; Poralla T; Manns M; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1992 Apr; 88(1):45-9. PubMed ID: 1532926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
    Rico MA; Quiroga JA; Subirá D; Garcia E; Castañón S; Sällberg M; Leroux-Roels G; Weiland O; Pardo M; Carreño V
    J Hepatol; 2002 Mar; 36(3):408-16. PubMed ID: 11867186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection.
    Bes M; Sauleda S; Casamitjana N; Piron M; Campos-Varela I; Quer J; Cubero M; Puig L; Guardia J; Esteban JI
    J Viral Hepat; 2012 Apr; 19(4):283-94. PubMed ID: 22404727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination.
    Schirren CA; Zachoval R; Gerlach JT; Ulsenheimer A; Gruener NH; Diepolder HM; Baretton G; Schraut W; Rau HG; Nitschko H; Pape GR; Jung MC
    J Hepatol; 2003 Sep; 39(3):397-404. PubMed ID: 12927926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.